115 related articles for article (PubMed ID: 26962720)
1. In vivo and in vitro metabolism of the designer anabolic steroid furazadrol in thoroughbred racehorses.
Waller CC; Cawley AT; Suann CJ; Ma P; McLeod MD
J Pharm Biomed Anal; 2016 May; 124():198-206. PubMed ID: 26962720
[TBL] [Abstract][Full Text] [Related]
2. The in vivo metabolism of Furazadrol in greyhounds.
Pranata A; Curtis B; Waller CC; Caldwell K; Zahra PW; Karamatic SL; McLeod MD
Drug Test Anal; 2021 Oct; 13(10):1749-1757. PubMed ID: 34254454
[TBL] [Abstract][Full Text] [Related]
3. Replacing PAPS: In vitro phase II sulfation of steroids with the liver S9 fraction employing ATP and sodium sulfate.
Weththasinghe SA; Waller CC; Fam HL; Stevenson BJ; Cawley AT; McLeod MD
Drug Test Anal; 2018 Feb; 10(2):330-339. PubMed ID: 28635171
[TBL] [Abstract][Full Text] [Related]
4. In vivo metabolism of the designer anabolic steroid hemapolin in the thoroughbred horse.
Waller CC; Weththasinghe SA; McClure L; Cawley AT; Suann C; Suann E; Sutherland E; Cooper E; Heather A; McLeod MD
Drug Test Anal; 2020 Jun; 12(6):752-762. PubMed ID: 31950580
[TBL] [Abstract][Full Text] [Related]
5. Metabolic studies of mesterolone in horses.
Ho EN; Leung DK; Leung GN; Wan TS; Wong HN; Xu X; Yeung JH
Anal Chim Acta; 2007 Jul; 596(1):149-55. PubMed ID: 17616252
[TBL] [Abstract][Full Text] [Related]
6. Identification and quantification of metabolites common to 17alpha-methyltestosterone and mestanolone in horse urine.
Yamada M; Aramaki S; Okayasu T; Hosoe T; Kurosawa M; Kijima-Suda I; Saito K; Nakazawa H
J Pharm Biomed Anal; 2007 Sep; 45(1):125-133. PubMed ID: 17709226
[TBL] [Abstract][Full Text] [Related]
7. Detection and metabolic investigations of a novel designer steroid: 3-chloro-17α-methyl-5α-androstan-17β-ol.
Cawley AT; Blakey K; Waller CC; McLeod MD; Boyd S; Heather A; McGrath KC; Handelsman DJ; Willis AC
Drug Test Anal; 2016 Jul; 8(7):621-32. PubMed ID: 27443417
[TBL] [Abstract][Full Text] [Related]
8. Metabolic study of androsta-1,4,6-triene-3,17-dione in horses using liquid chromatography/high resolution mass spectrometry.
Kwok WH; Leung GN; Wan TS; Curl P; Schiff PJ
J Steroid Biochem Mol Biol; 2015 Aug; 152():142-54. PubMed ID: 26031748
[TBL] [Abstract][Full Text] [Related]
9. The in vivo metabolism of Jungle Warfare in greyhounds.
Pranata A; Yamada S; Weththasinghe S; Caldwell K; Zahra PW; Karamatic SL; Gardiner MG; McLeod MD
Steroids; 2023 Feb; 190():109150. PubMed ID: 36511323
[TBL] [Abstract][Full Text] [Related]
10. Metabolic studies of oxyguno in horses.
Wong AS; Ho EN; Wan TS; Lam KK; Stewart BD
Anal Chim Acta; 2015 Sep; 891():190-202. PubMed ID: 26388378
[TBL] [Abstract][Full Text] [Related]
11. Endocrine characterization of the designer steroid methyl-1-testosterone: investigations on tissue-specific anabolic-androgenic potency, side effects, and metabolism.
Parr MK; Blatt C; Zierau O; Hess C; Gütschow M; Fusshöller G; Opfermann G; Schänzer W; Diel P
Endocrinology; 2011 Dec; 152(12):4718-28. PubMed ID: 21990312
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of 4-hydroxyandrostenedione and 4-hydroxytestosterone: Mass spectrometric identification of urinary metabolites.
Kohler M; Parr MK; Opfermann G; Thevis M; Schlörer N; Marner FJ; Schänzer W
Steroids; 2007 Mar; 72(3):278-86. PubMed ID: 17207827
[TBL] [Abstract][Full Text] [Related]
13. Analysis of anabolic steroids in the horse: development of a generic ELISA for the screening of 17alpha-alkyl anabolic steroid metabolites.
Hungerford NL; Sortais B; Smart CG; McKinney AR; Ridley DD; Stenhouse AM; Suann CJ; Munn KJ; Sillence MN; McLeod MD
J Steroid Biochem Mol Biol; 2005 Aug; 96(3-4):317-34. PubMed ID: 16040239
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo metabolism of the anabolic-androgenic steroid oxandrolone in the horse.
Harding C; Viljanto M; Cutler C; Habershon-Butcher J; Biddle S; Scarth J
Drug Test Anal; 2022 Jan; 14(1):39-55. PubMed ID: 34378336
[TBL] [Abstract][Full Text] [Related]
15. Metabolic studies of 1-testosterone in horses.
Kwok WH; Ho EN; Leung GN; Tang FP; Wan TS; Wong HN; Yeung JH
Drug Test Anal; 2013 Feb; 5(2):81-8. PubMed ID: 22715048
[TBL] [Abstract][Full Text] [Related]
16. Comparison of sulfo-conjugated and gluco-conjugated urinary metabolites for detection of methenolone misuse in doping control by LC-HRMS, GC-MS and GC-HRMS.
Fragkaki AG; Angelis YS; Kiousi P; Georgakopoulos CG; Lyris E
J Mass Spectrom; 2015 May; 50(5):740-8. PubMed ID: 26259657
[TBL] [Abstract][Full Text] [Related]
17. A review of designer anabolic steroids in equine sports.
Waller CC; McLeod MD
Drug Test Anal; 2017 Sep; 9(9):1304-1319. PubMed ID: 27732767
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro metabolism of the 'designer' steroid estra-4,9-diene-3,17-dione between the equine, canine and human: identification of target metabolites for use in sports doping control.
Scarth JP; Clarke AD; Teale P; Pearce CM
Steroids; 2010 Oct; 75(10):643-52. PubMed ID: 20381511
[TBL] [Abstract][Full Text] [Related]
19. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
20. Detection of stanozolol and its metabolites in equine urine by liquid chromatography-electrospray ionization ion trap mass spectrometry.
McKinney AR; Suann CJ; Dunstan AJ; Mulley SL; Ridley DD; Stenhouse AM
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Nov; 811(1):75-83. PubMed ID: 15458725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
